Consensus American Well Corporation

Equities

AMWL

US03044L2043

Market Closed - Nyse Other stock markets 21:00:02 06/09/2024 BST			5-day change	1st Jan Change
7.930 ^USD	-1.25%		-4.46%	-73.39%

09-04	Transcript : American Well Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 01:50 PM
07-31	Transcript : American Well Corporation, Q2 2024 Earnings Call, Jul 31, 2024

Evolution of the Average Target: American Well Corporation

Evolution of the Target Price: American Well Corporation

Changes in Analyst Recommendations: American Well Corporation

378604279cd73e0.Dr7fQimN82FP26phSVXcFq1ycgS7MkznwVRweeOwbo8.S9iJdUDohAwD9tA0KGC1Z94ZCnHoR3y3g2xIA7roXsE20JB6Y7mrMyOCyQ~0b31abc87ad29bf79cdbf38d33c84a98

Analysts' recommendations: American Well Corporation

UBS Adjusts American Well Price Target to $0.60 From $1.50, Maintains Neutral Rating	05-23	MT
Morgan Stanley Adjusts American Well's Price Target to $1 From $1.75, Keeps Equalweight Rating	04-15	MT
UBS Adjusts American Well Price Target to $1.30 From $2.60, Maintains Neutral Rating	11-08	MT
UBS Adjusts Price Target on American Well to $2.60 From $2.80, Maintains Neutral Rating	04/08/23	MT
Morgan Stanley Downgrades American Well to Equalweight From Overweight, Halves PT to $2.50 From $5, Cites Weaker-Than-Expected Growth	03/08/23	MT
Credit Suisse Trims American Well's Price Target to $3.50 From $4 After Lower-Than-Expected Q1 Results, Keeps Neutral Rating	04/05/23	MT
TD Cowen Downgrades American Well to Market Perform From Outperform, Adjusts Price Target to $2.50 From $5	23/03/23	MT
Morgan Stanley Adjusts Price Target on American Well to $5 From $6, Maintains Overweight Rating	13/03/23	MT
UBS Adjusts American Well Price Target to $3.10 From $4.20, Maintains Neutral Rating	28/02/23	MT
Piper Sandler Downgrades American Well to Neutral From Overweight, Adjusts Price Target to $3.50 From $5	27/02/23	MT
Credit Suisse Trims American Well's Price Target to $4 From $5 on Lower-Than-Expected 2023 Outlook, Keeps Neutral Rating	23/02/23	MT
Morgan Stanley Cuts Price Target on American Well to $6 From $7, Reiterates Overweight Rating	06/01/23	MT
BofA Securities Upgrades American Well to Buy From Neutral, Price Target is $4.20	04/01/23	MT
Truist Securities Starts American Well at Hold With $5 Price Target	07/09/22	MT
Piper Sandler Adjusts American Well's Price Target to $5 From $6, Reiterates Overweight Rating	07/09/22	MT
UBS Adjusts American Well Price Target to $4.20 From $3.25, Maintains Neutral Rating	08/08/22	MT
Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors	01/07/22	MT
Piper Sandler Adjusts American Well's Price Target to $6 From $5, Maintains Overweight Rating	23/06/22	MT
Goldman Sachs Adjusts Price Target for American Well to $4.50 From $5, Maintains Neutral Rating	26/05/22	MT
Piper Sandler Adjusts American Well's Price Target to $5 From $7, Reiterates Overweight Rating	17/05/22	MT
Morgan Stanley Lowers American Well's Price Target to $7 From $9, Maintains Overweight Rating	10/05/22	MT
Guggenheim Initiates American Well With Buy Rating, $6 Price Target	13/04/22	MT
UBS Adjusts American Well Price Target to $4 From $10, Maintains Neutral Rating	08/03/22	MT
Wells Fargo Adjusts American Well's Price Target to $4 from $6, Keeps Equalweight Rating	28/02/22	MT
Piper Sandler Adjusts American Well's Price Target to $7 From $12, Reiterates Overweight Rating	25/02/22	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analyst Opinion	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	AMERICAN WELL CORPORATION					+129.79%
	HIMS & HERS HEALTH, INC.					+62.74%
	TELADOC HEALTH, INC.					+29.99%
	TALKSPACE, INC.					+95.53%
	Average					+79.51%
	Weighted average by Cap.					+57.54%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

7.930USD

Average target price

18.22USD

Spread / Average Target

+129.79%

High Price Target

66.00USD

Spread / Highest target

+732.28%

Low Price Target

9.000USD

Spread / Lowest Target

+13.49%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
Morgan Stanley
Credit Suisse
TD Cowen
Piper Sandler
BofA Securities
Truist Securities
Goldman Sachs
Guggenheim
Wells Fargo Securities
Jefferies & Co.
Berenberg Bank
Cowen
Cantor Fitzgerald
KeyBanc Capital Markets
Needham & Co.